Glaucoma Research

Investigating Disease Progression

Glaucoma is the leading cause of irreversible blindness worldwide. Our research team is dedicated to advancing the early detection and management of glaucoma. We are currently seeking participants for several clinical studies focused on diagnosing glaucoma and investigating disease progression.

By joining our study, you will contribute to crucial research that could transform how glaucoma is diagnosed and managed. Our team collaborates closely with various funding organizations, including the National Institutes of Health. Please find further details about the clinical studies below, and we encourage you to reach out for more information about participating in this important research initiative.

Studies

Study 1

Focuses on the XyCAM RI, a non-invasive tool designed to assess blood flow in the eye. This innovative approach aims to enhance diagnostic accuracy for early-stage glaucoma, potentially leading to improved treatment outcomes.

Study 2

Focuses on the vascular components of glaucoma, exploring how blood flow to the optic nerve may influence the disease’s progression. By utilizing advanced techniques like erythrocyte-mediated Indocyanine Green angiography and fluorescence-mediated photoplethysmography, we aim to measure blood flow and vasomotion at the optic nerve head, potentially revealing critical insights into the underlying mechanisms of glaucoma.